P. Arvaniti

发表

FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases.

G. Dalekos, N. Gatselis, G. Koukoulis, 2020, Annals of hepatology.

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients

E. Rigopoulou, G. Dalekos, N. Gatselis, 2022, Frontiers in Immunology.

Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome

G. Dalekos, N. Gatselis, V. Lygoura, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed.

E. Rigopoulou, G. Dalekos, N. Gatselis, 2021, European journal of internal medicine.

Prompt initiation of high‐dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis

G. Dalekos, A. Lyberopoulou, N. Gatselis, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Mediterranean Journal of Hematology and Infectious Diseases Patients with Haemoglobinopathies and Chronic Hepatitis C: a Real Difficult to Treat Population in 2016?

E. Rigopoulou, G. Dalekos, N. Gatselis, 2022 .

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

E. Rigopoulou, G. Dalekos, N. Gatselis, 2016, Alimentary pharmacology & therapeutics.

Treatment of chronic hepatitis C with direct‐acting antivirals in patients with β‐thalassaemia major and advanced liver disease

I. Goulis, J. Koskinas, Konstantinos Maragkos, 2017, British Journal of Haematology.

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars

V. Spyrou, C. Billinis, G. Dalekos, 2022, Annals of gastroenterology.

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis

G. Dalekos, G. Koukoulis, K. Zachou, 2020, JHEP reports : innovation in hepatology.

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis

E. Rigopoulou, G. Dalekos, N. Gatselis, 2022, JHEP reports : innovation in hepatology.

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece.

E. Rigopoulou, G. Dalekos, N. Gatselis, 2017, European journal of internal medicine.

Impact of genetic and environmental factors on autoimmune hepatitis

G. Dalekos, A. Lyberopoulou, K. Zachou, 2021, Journal of translational autoimmunity.

JAK Inhibitors and Oxidative Stress Control

A. Bordron, C. Le Dantec, Yves Renaudineau, 2019, Front. Immunol..

Linking genetic variation with epigenetic profiles in Sjögren's syndrome.

C. Dantec, Yves Renaudineau, C. Hedrich, 2019, Clinical immunology.

Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis

G. Dalekos, G. Koukoulis, K. Zachou, 2018, Case reports in hepatology.

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis

W. Brooks, Yves Renaudineau, G. Dalekos, 2019, Epigenomes.

Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.

G. Hadjigeorgiou, E. Rigopoulou, G. Dalekos, 2019, Clinics and research in hepatology and gastroenterology.

JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren’s Syndrome

C. Le Dantec, M. Arleevskaya, Yves Renaudineau, 2019, Clinical Reviews in Allergy & Immunology.

Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis

Yves Renaudineau, A. Lyberopoulou, M. Ioannou, 2021, medRxiv.

Psychological nursing support for elderly patients undergoing chronic regular haemodialysis.

P. Arvaniti, D. Michalopoulos, E. Triantaphillopoulou, 1998, EDTNA/ERCA journal.

A real‐world study focused on the long‐term efficacy of mycophenolate mofetil as first‐line treatment of autoimmune hepatitis

E. Rigopoulou, G. Dalekos, N. Gatselis, 2016, Alimentary pharmacology & therapeutics.

Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.

A. Floreani, A. Takaki, E. Rigopoulou, 2023, European journal of internal medicine.

Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?

G. Dalekos, P. Arvaniti, I. Olivas, 2024, Exploration of Digestive Diseases.

Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?

E. Rigopoulou, G. Dalekos, N. Gatselis, 2016, Mediterranean journal of hematology and infectious diseases.